ArticleBlood advances2020

Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.

Duncan Purtill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.